Affinity Asset Advisors, LLC Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$358.3B
Holdings
56
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (56 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 250,000 | $89.3B | 24.92% | Put |
| 2 | SNYSANOFI | 550,000 | $20.9B | 5.84% | Put |
| 3 | ESTAESTABLISHMENT LABS HLDGS INC | 326,668 | $17.8B | 4.98% | |
| 4 | 290ACHINOOK THERAPEUTICS INC | 813,998 | $16.0B | 4.47% | |
| 5 | AZNASTRAZENECA PLC | 250,000 | $13.7B | 3.83% | Put |
| 6 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 190,000 | $12.9B | 3.61% | |
| 7 | IWMISHARES TR | 70,000 | $11.5B | 3.22% | Put |
| 8 | MDGLMADRIGAL PHARMACEUTICALS INC | 175,000 | $11.4B | 3.17% | Put |
| 9 | LNTHLANTHEUS HLDGS INC | 160,000 | $11.3B | 3.14% | Put |
| 10 | TVTX 2.5 09/15/25TRAVERE THERAPEUTICS INC | 11,000,000 | $11.1B | 3.11% | |
| 11 | ASNDASCENDIS PHARMA A/S | 100,000 | $10.3B | 2.88% | |
| 12 | KURAKURA ONCOLOGY INC | 712,853 | $9.7B | 2.72% | Put |
| 13 | NARIUSDINARI MED INC | 120,000 | $8.7B | 2.43% | |
| 14 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 10,000,000 | $8.5B | 2.38% | |
| 15 | VTYXVENTYX BIOSCIENCES INC | 170,000 | $5.9B | 1.66% | |
| 16 | —POINT BIOPHARMA GLOBAL INC | 746,576 | $5.8B | 1.61% | |
| 17 | GSKGSK PLC | 185,000 | $5.4B | 1.52% | Put |
| 18 | VRNAVERONA PHARMA PLC | 515,100 | $5.3B | 1.47% | Put |
| 19 | BLUBELLUS HEALTH INC NEW | 473,597 | $5.0B | 1.40% | |
| 20 | SWTXSPRINGWORKS THERAPEUTICS INC | 175,000 | $5.0B | 1.39% | |
| 21 | PENPENUMBRA INC | 25,000 | $4.7B | 1.32% | Call |
| 22 | CBAYUSDCYMABAY THERAPEUTICS INC | 1,290,511 | $4.5B | 1.26% | |
| 23 | BBIO 2.5 03/15/27BRIDGEBIO PHARMA INC | 7,500,000 | $4.5B | 1.25% | |
| 24 | BBIO 2.25 02/01/29BRIDGEBIO PHARMA INC | 10,000,000 | $4.4B | 1.24% | |
| 25 | RCKTROCKET PHARMACEUTICALS INC | 267,794 | $4.3B | 1.19% | |
| 26 | MORFMORPHIC HLDG INC | 146,491 | $4.1B | 1.16% | |
| 27 | ACLXARCELLX INC | 210,138 | $3.9B | 1.10% | |
| 28 | ZNTLZENTALIS PHARMACEUTICALS INC | 170,000 | $3.7B | 1.03% | |
| 29 | CATBUSDASTRIA THERAPEUTICS INC | 400,043 | $3.6B | 1.01% | |
| 30 | —ARYA SCIENCES ACQUISITN CORP | 352,500 | $3.5B | 0.97% | |
| 31 | CYTKCYTOKINETICS INC | 65,000 | $3.1B | 0.88% | |
| 32 | GONGERON CORP | 1,276,000 | $3.0B | 0.83% | Put |
| 33 | COGTCOGENT BIOSCIENCES INC | 154,087 | $2.3B | 0.64% | |
| 34 | TCE2CELLDEX THERAPEUTICS INC NEW | 80,000 | $2.2B | 0.63% | |
| 35 | ACRSACLARIS THERAPEUTICS INC | 136,434 | $2.1B | 0.60% | |
| 36 | —VINCERX PHARMA INC | 1,492,771 | $2.1B | 0.57% | |
| 37 | FXEINVESCO CURRENCYSHARES EURO | 20,000 | $1.8B | 0.50% | Put |
| 38 | —PROMETHEUS BIOSCIENCES INC | 25,000 | $1.5B | 0.41% | |
| 39 | —PRECIGEN INC | 1,500,000 | $1.5B | 0.41% | |
| 40 | KALVKALVISTA PHARMACEUTICALS INC | 96,318 | $1.4B | 0.39% | |
| 41 | MISTMILESTONE PHARMACEUTICALS IN | 137,200 | $1.3B | 0.35% | Call |
| 42 | LIANYLIANBIO | 550,000 | $1.1B | 0.31% | |
| 43 | FXBINVESCO CURRENCYSHARES BRIT | 10,000 | $1.1B | 0.30% | Put |
| 44 | CNTXCONTEXT THERAPEUTICS INC | 883,654 | $981.0M | 0.27% | |
| 45 | CNTACENTESSA PHARMACEUTICALS PLC | 242,517 | $975.0M | 0.27% | |
| 46 | NVLSEURALPINE IMMUNE SCIENCES INC | 110,000 | $792.0M | 0.22% | |
| 47 | NAUTNAUTILUS BIOTECHNOLOGY INC | 372,476 | $790.0M | 0.22% | |
| 48 | VERVVERVE THERAPEUTICS INC | 20,000 | $687.0M | 0.19% | Call |
| 49 | VKTXVIKING THERAPEUTICS INC | 250,000 | $680.0M | 0.19% | |
| 50 | OPHTEURIVERIC BIO INC | 30,000 | $538.0M | 0.15% | Call |
| 51 | IMTXIMMATICS N.V | 187,204 | $507.0M | 0.14% | |
| 52 | —RENOVACOR INC | 199,490 | $503.0M | 0.14% | |
| 53 | TNGXTANGO THERAPEUTICS INC | 81,982 | $297.0M | 0.08% | |
| 54 | —VICKERS VANTAGE CORP I | 100,000 | $17.0M | 0.00% | |
| 55 | —RENOVACOR INC | 75,000 | $6.0M | 0.00% | |
| 56 | —MEDICUS SCIENCES ACQUISITION | 33,333 | $3.0M | 0.00% |